Najmeh Maharlouei

Najmeh Maharlouei

Auto-generated profile, based on publicly available information

Najmeh Maharlouei

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2018 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
NMNajmeh Maharlouei
Najmeh Maharlouei
RTReza Tabrizi
Reza Tabrizi
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
ARAbbas Rezaianzadeh
Abbas Rezaianzadeh
MAMaryam Akbari
Maryam Akbari
ZAZatollah Asemi
Zatollah Asemi
This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of ginger intake on weight loss, glycemic control and lipid profiles among overweight and obese subjects. We searched the following databases through November 2017: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The relevant data were extracted and assessed for quality of the studies according to the Cochrane risk of bias tool. Data were pooled using the inverse variance method and expressed as Standardized Mean Difference (SMD) with 95% Confidence Intervals (95% CI). Heterogeneity between studies was assessed by the Cochran Q statistic and I-squared tests (I2). Overall, 14 studies were included in the meta-analyses. Fourteen RCTs with 473 subjects were included in our meta-analysis. The results indicated that the supplementation with ginger significantly decreased body weight (BW) (SMD −0.66; 95% CI, −1.31, −0.01; P = 0.04), waist-to-hip ratio (WHR) (SMD −0.49; 95% CI, −0.82, −0.17; P = 0.003), hip ratio (HR) (SMD −0.42; 95% CI, −0.77, −0.08; P = 0.01), fasting glucose (SMD −0.68; 95% CI, −1.23, −0.05; P = 0.03) and insulin resistance index (HOMA-IR) (SMD −1.67; 95% CI, −2.86, −0.48; P = 0.006), and significantly increased HDL-cholesterol levels (SMD 0.40; 95% CI, 0.10, 0.70; P = 0.009). We found no detrimental effect of ginger on body mass index (BMI) (SMD −0.65; 95% CI, −1.36, 0.06; P = 0.074), insulin (SMD −0.54; 95% CI, −1.43, 0.35; P = 0.23), triglycerides (SMD −0.27; 95% CI, −0.71, 0.18; P = 0.24), total- (SMD −0.20; 95% CI, −0.58, 0.18; P = 0.30) and LDL-cholesterol (SMD −0.13; 95% CI, −0.51, 0.24; P = 0.48). Overall, the current meta-analysis demonstrated that ginger intake reduced BW, WHR, HR, fasting glucose and HOMA-IR, and increased HDL-cholesterol, but did not affect insulin, BMI, triglycerides, total- and LDL-cholesterol levels.

1 November 2017 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MMMahmood Moosazadeh
Mahmood Moosazadeh
ZAZatollah Asemi
Zatollah Asemi
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
RTReza Tabrizi
Reza Tabrizi
NMNajmeh Maharlouei
Najmeh Maharlouei
MAMaryam Akbari
Maryam Akbari

23 May 2013 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
FGFariborz Ghaffarpasand
Fariborz Ghaffarpasand
MMMojtaba Mahmoodi
Mojtaba Mahmoodi
MLMehrzad Lotfi
Mehrzad Lotfi
NZNima Zamiria
Nima Zamiria
BGBita Geramizadeh
Bita Geramizadeh
Background: Population based studies on prevalence and risk factors of NAFLD in Iranian population are few. The prevalence of NAFLD and non alcoholic steatohepatitis (NASH) in Iranians varies from 2.9% to 7.1% in general population and 55.8% in patients with type 2 diabetes mellitus. Objectives: To determine the prevalence and determinants of non alcoholic fatty liver disease (NAFLD) in a sample of adult Iranian general population. Patients and Methods: This was a cross-sectional study being performed in Shiraz, southern Iran during a 10-month period from November 2010 to September 2011 through cluster random sampling of Iranian general population in Shiraz region. All individuals undergone anthropometric, blood pressure measurements, thorough medical history and physical examinations. Laboratory measurements included fasting blood glucose (FBS), lipid profile, complete blood count (CBC) and liver function tests. NAFLD was diagnosed by transabdominal ultrasonography. Results: 819 subjects were included in this study among which were 340 males (41.5%) and 479 females (58.5%) with the mean age of 43.1 ± 14.1 years. NAFLD was diagnosed in 176 (21.5%) subjects. Patients with NAFLD were significantly older (P < 0.001), had higher proportion of male gender (P = 0.004) and had higher BMI (P < 0.001). They also had higher prevalence of hypertension (P < 0.001), high FBS (P < 0.001), high cholesterol (P = 0.026), high triglyceride (P < 0.001) and high waist circumference (P < 0.001). Taking all these together, patients with NAFLD had significantly higher prevalence of metabolic syndrome when compared to healthy subjects (P < 0.001). Conclusion: The prevalence of NAFLD in this group of Iranian adult general population is 21.5%. NAFLD in Iranian population is associated with male gender, old age, obesity, and features of metabolic syndrome. Keywords: Non alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Metabolic Syndrome; Iran

5 June 2020 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
MMMehdi Moradinazar
Mehdi Moradinazar
FNFarid Najafi
Farid Najafi
FJFarzad Jalilian
Farzad Jalilian
YPYahya Pasdar
Yahya Pasdar
BHBehrooz Hamzeh
Behrooz Hamzeh
MMMehdi Mirzaei-Alavijeh
Mehdi Mirzaei-Alavijeh
Background: Drug use can lead to several psychological, medical and social complications. The current study aimed to measure and decomposes socioeconomic-related inequalities in drug use among adults in Iran. Methods: This was a cross-sectional study The PERSIAN Cohort is the largest and most important cohort among 18 distinct areas of Iran. This study was conducted on 130,570 adults 35 years and older. A structured questionnaire was applied to collect data. The concentration index (C) was used to quantify and decompose socioeconomic inequalities in drug use. Results: The prevalence experience of drug use was 11.9%. The estimated C for drug use was − 0.021. The corresponding value of the C for women and men were − 0.171 and − 0.134, respectively. The negative values of the C suggest that drug use is more concentrated among the population with low socioeconomic status in Iran (p < 0.001). For women, socioeconomic status (SES) (26.37%), province residence (− 22.38%) and age (9.76%) had the most significant contribution to socioeconomic inequality in drug use, respectively. For men, SES (80.04%), smoking (32.04%) and alcohol consumption (− 12.37%) were the main contributors to socioeconomic inequality in drug use. Conclusions: Our study indicated that drug use prevention programs in Iran should focus on socioeconomically disadvantaged population. Our finding could be useful for health policy maker to design and implement effective preventative programs to protect Iranian population against the drug use.

21 October 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AKAli Kazemi Karyani
Ali Kazemi Karyani
BMBehzad Karmi Matin
Behzad Karmi Matin
SSShahin Soltani
Shahin Soltani
SRSatar Rezaei
Satar Rezaei
MSMoslem Soofi
Moslem Soofi
FNFarid Najafi
Farid Najafi
Background: The level of socioeconomic-related inequality in physical activity in Iran is largely unknown. This study investigates socioeconomic-related inequality in poor-physical activity (PPA) among Iranian adults. Methods: A total of 129,257 adult participants enrolled in the PERSIAN (Prospective Epidemiological Research Studies in IrAN) Cohort were included in this study. Physical activity of adults was measured using metabolic equivalent rates (METs). Physical activity less than 41 METs/hour/day was considered PPA. The Concentration index (C) was used to quantify socioeconomic-related inequality in PPA. Moreover, the C was decomposed to identify the relative contribution of explanatory variables to inequality in PPA. Results: There were significant regional variations in physical activity level among Iranian adults (29.8–76.5%). The positive value of C (0.098, 95% CI = 0.092 to 0.104) suggested that the higher concentration of PPA among higher socioeconomic status (SES) adults in Iran which was consistently observed in all cohort sites. Conclusions: The higher prevalence of PPA among Iranian adults, especially, women and older adults, warrant further public health attention. Since PPA is concentrated more among the high-SES population in Iran, strategies for the promotion of physical activity should focus more on economically well-off population.

22 December 2003 in Journal of Clinical Nursing
Verified
Journal Article
Closed access
PDF file
JAJamshid Ahmadi
Jamshid Ahmadi
NMNajmeh Maharlooy
Najmeh Maharlooy
MAMohammadjavad Alishahi
Mohammadjavad Alishahi